Published in Hematology Week, May 21st, 2007
"I'm honored to welcome Dr. Tuttle as Vice President of Research and Development," commented Mr. Frank Menzler, President and CEO of HepaLife Technologies, Inc. "Dr. Tuttle's appointment follows important research and development successes at HepaLife, prompting the expansion of our...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week